Effects of naloxone on nitrous oxide actions in healthy volunteers

被引:17
作者
Zacny, JP [1 ]
Conran, A [1 ]
Pardo, H [1 ]
Coalson, DW [1 ]
Black, M [1 ]
Klock, PA [1 ]
Klafta, JM [1 ]
机构
[1] Univ Chicago, DACC MC4028, Chicago, IL 60637 USA
关键词
nitrous oxide; naloxone; opioid; pain; analgesia; behavior;
D O I
10.1016/S0304-3959(99)00127-X
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A number of studies have examined the effects of naloxone on nitrous oxide-induced analgesia with conflicting results. In the present study the effects of st relatively high dose of naloxone was examined to determine its effects on nitrous oxide-induced analgesia, as well as on the subjective and psychomotor effects of nitrous oxide. Fourteen subjects participated in a four-session crossover trial in which they received intravenous injections of either saline or 30 mg/70 kg naloxone 10 min into a 35 min period in which they were inhaling either 100% oxygen or 30% nitrous oxide in oxygen. Ten minutes after the naloxone administration, subjects were tested on the cold presser test. Mood and psychomotor performance were also assessed before, during and after the inhalation period. Subjects reported higher pain ratings after the naloxone injection than the saline injection, but there was no evidence of naloxone reversing the analgesic effects of nitrous oxide. Similarly while naloxone also affected mood and impaired psychomotor performance, there was no evidence of naloxone reversing the effect of nitrous oxide on these measures. The results of this study call into question the role of the opioidergic system in mediating various effects of nitrous oxide in humans. (C) 1999 International Association for the Study of Pain. Published by Elsevier Science B.V.
引用
收藏
页码:411 / 418
页数:8
相关论文
共 59 条
[31]   ANALYSIS OF 1,331 SEDATIONS USING INHALATION, INTRAVENOUS, OR OTHER TECHNIQUES [J].
JASTAK, JT ;
PARAVECCHIO, R .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1975, 91 (06) :1242-1249
[32]   Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin [J].
Jevtovic-Todorovic, V ;
Todorovic, SM ;
Mennerick, S ;
Powell, S ;
Dikranian, K ;
Benshoff, N ;
Zorumski, CF ;
Olney, JW .
NATURE MEDICINE, 1998, 4 (04) :460-463
[33]  
JUDD LL, 1980, ARCH GEN PSYCHIAT, V37, P583
[34]   THE PSYCHOPHARMACOLOGIC AND PROLACTIN RESPONSE AFTER LARGE DOSES OF NALOXONE IN MAN [J].
KUMOR, KM ;
HAERTZEN, CA ;
JASINSKI, DR ;
JOHNSON, RE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 30 (04) :967-975
[35]   OPIATE-LIKE ANALGESIC ACTIVITY IN GENERAL-ANESTHETICS [J].
LAWRENCE, D ;
LIVINGSTON, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (02) :435-442
[36]   NALOXONE DOSE DEPENDENTLY PRODUCES ANALGESIA AND HYPERALGESIA IN POST-OPERATIVE PAIN [J].
LEVINE, JD ;
GORDON, NC ;
FIELDS, HL .
NATURE, 1979, 278 (5706) :740-741
[37]   NALOXONE FAILS TO ANTAGONIZE NITROUS-OXIDE ANALGESIA FOR CLINICAL PAIN [J].
LEVINE, JD ;
GORDON, NC ;
FIELDS, HL .
PAIN, 1982, 13 (02) :165-170
[38]  
MARTIN WR, 1971, CLIN PHARMACOL THER, V12, P245
[39]   THE SHORT-FORM MCGILL PAIN QUESTIONNAIRE [J].
MELZACK, R .
PAIN, 1987, 30 (02) :191-197
[40]   Diagnostic and Statistical Manual of Mental Disorders [J].
Mittal, Vijay A. ;
Walker, Elaine F. .
PSYCHIATRY RESEARCH, 2011, 189 (01) :158-159